Hall H, Sällemark M, Jerning E
Acta Pharmacol Toxicol (Copenh). 1986 Jan;58(1):61-70. doi: 10.1111/j.1600-0773.1986.tb00071.x.
A number of potential neuroleptic drugs of the substituted benzamide type have been compared with some reference neuroleptic drugs regarding their affinities for rat brain receptors using in vitro receptor binding techniques. The effects on dopamine-stimulated adenylate cyclase were also investigated. All 6-methoxysalicylamides were very potent inhibitors of the dopamine-D2 receptor and possessed much less affinity for other receptors as well as for the dopamine-stimulated adenylate cyclase. In contrast, the classical neuroleptic drugs were not selective dopamine-D2 receptor blockers. Several of these neuroleptics were thus potent inhibitors of alpha 1-receptors, 5-HT2 receptors, muscarinic receptors and histamine-H1 receptors. Sulpiride was the most selective dopamine-D2 receptor blocker of the reference compounds with a selectivity ratio of 65. The 6-methoxysalicylamides had selectivity ratios ranging from 18 to 167.
利用体外受体结合技术,已将多种潜在的取代苯甲酰胺类抗精神病药物与一些参考抗精神病药物就其对大鼠脑受体的亲和力进行了比较。还研究了它们对多巴胺刺激的腺苷酸环化酶的影响。所有6-甲氧基水杨酰胺都是多巴胺-D2受体的强效抑制剂,对其他受体以及多巴胺刺激的腺苷酸环化酶的亲和力也低得多。相比之下,经典抗精神病药物不是选择性多巴胺-D2受体阻滞剂。因此,其中几种抗精神病药物是α1受体、5-HT2受体、毒蕈碱受体和组胺-H1受体的强效抑制剂。舒必利是参考化合物中最具选择性的多巴胺-D2受体阻滞剂,选择性比为65。6-甲氧基水杨酰胺的选择性比在18至167之间。